Skip to main content
Apcotex Industries Limited logo

Apcotex Industries Limited — Investor Relations & Filings

Ticker · APCOTEXIND ISIN · INE116A01032 LEI · 335800HG4J9YCBEO5Y85 BSE.NS Manufacturing
Filings indexed 969 across all filing types
Latest filing 2024-11-21 Regulatory Filings
Country IN India
Listing BSE.NS APCOTEXIND

About Apcotex Industries Limited

https://apcotex.com/

Apcotex Industries Limited is a leading manufacturer of synthetic rubber and synthetic latex, specializing in the production of a diverse range of emulsion polymers. The company's core product portfolio includes Nitrile Butadiene Rubber (NBR), High Styrene Rubber (HSR), Styrene Butadiene (SBR) Latex, Vinyl Pyridine (VP) Latex, and Carboxylated Nitrile Latex. These materials are utilized across various applications, including automotive components, footwear, paper coating, construction, textiles, and carpet backing. Apcotex is distinguished by its extensive technical expertise and robust research and development capabilities, operating advanced manufacturing facilities to deliver high-performance solutions. Key offerings also include specialized latex for the dipping industry, specifically for examination gloves and tire cord applications, catering to both domestic and international markets with a focus on quality and innovation.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the schedule of meetings with institutional investors, analysts, and investment advisors. It explicitly states that no unpublished price sensitive information will be shared. The document is a notification to stock exchanges about upcoming investor meetings, not a financial report or earnings release. The document length is short (1625 characters), and it serves as an announcement of investor interaction rather than detailed financial data or analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2024-11-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document contains a detailed transcript of an earnings conference call held on October 25, 2024, discussing the financial results for the quarter and half year ended September 30, 2024. It includes management's opening remarks, financial performance metrics such as revenue, EBITDA, and net profit, and a Q&A session with analysts. The content is a full text transcript of the earnings call, not just an announcement or summary. Therefore, the document fits the definition of a Call Transcript (CT).
2024-10-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them about the availability of the audio recording of the earnings conference call held on 25th October 2024. It references the financial results for the quarter and half year ended 30th September 2024. The document does not contain the transcript itself, nor detailed financial data, but rather informs that the recording is hosted on the company's website. The document length is short (1312 characters) and serves as an announcement rather than the actual call transcript. According to the rules, announcements about availability of conference call recordings or transcripts should be classified as Regulatory Filings (RNS) because it is a notification and not the full transcript.
2024-10-25 English
Copy of Newspaper Publication
Regulatory Filings
2024-10-25 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Earnings Presentation – September 2024 (Q2 – FY 2024-25)' and contains detailed financial data including quarterly and half-yearly operational revenue, EBITDA, PAT, EPS, balance sheet data, and operational highlights for Q2 and H1 of FY25. It is addressed to stock exchanges and includes a CFO signature, indicating an official investor communication. The content is a detailed presentation of financial results and business overview, typical of an investor presentation rather than a brief earnings release or a full annual/interim report. The length (15,000 characters) and detailed financial and operational data confirm it is not a mere announcement or summary. Therefore, the document fits the category of an Investor Presentation (IP).
2024-10-25 English
Updates
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges providing details of Key Managerial Personnel (KMP) under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It lists names and designations of KMPs authorized for disclosures. There is no financial data, no report attached or referenced, and it is an announcement related to management information. This fits the category of Board/Management Information (MANG) as it concerns disclosure about key management personnel.
2024-10-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.